Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Wingard

Showing results (171-180 of 267) with videos related to

Pageof 27
Sort By:
Journal of Clinical Microbiology|October 18, 2014
Reply to "Insufficient demonstration of long-term stability of Aspergillus galactomannan"L Joseph Wheat, M Hong Nguyen, Barbara D Alexander, et al.
Journal of the Pediatric Infectious Diseases Society|June 26, 2021
Prospective Evaluation of Galactomannan and (1→3) β-d-Glucan Assays as Diagnostic Tools for Invasive Fungal Disease in Children, Adolescents, and Young Adults With Acute Myeloid Leukemia Receiving Fungal ProphylaxisBrian T Fisher, Ted Westling, Craig L K Boge, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Blood and marrow transplant clinical trials network state of the Science Symposium 2014Frederick R Appelbaum, Claudio Anasetti, Joseph H Antin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2011
Umbilical cord blood transplantation for children with thalassemia and sickle cell diseaseAnnalisa Ruggeri, Mary Eapen, Andromachi Scaravadou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2010
Generic immunosuppressants in hematopoietic cell transplantationCorey Cutler, Aaron Kesselheim, Steven Gabardi, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 15, 2013
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplantsJosephine Mauskopf, Costel Chirila, Jon Graham, et al.
Blood|October 31, 2008
Solid cancers after allogeneic hematopoietic cell transplantationJ Douglas Rizzo, Rochelle E Curtis, Gérard Socié, et al.
Transplantation and Cellular Therapy|October 23, 2022
Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of HematologyFareed Khawaja, Genovefa Papanicolaou, Sanjeet Dadwal, et al.
Blood Cancer Journal|November 28, 2017
Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemiaMaxim Norkin, Lakshmikanth Katragadda, Fei Zou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 20, 2011
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationNavneet S Majhail, J Douglas Rizzo, Stephanie J Lee, et al.
Pageof 27

Showing results (171-180 of 267) with videos related to

Sort By:
Pageof 27
Journal of Clinical Microbiology|October 18, 2014
Reply to "Insufficient demonstration of long-term stability of Aspergillus galactomannan"L Joseph Wheat, M Hong Nguyen, Barbara D Alexander, et al.
Journal of the Pediatric Infectious Diseases Society|June 26, 2021
Prospective Evaluation of Galactomannan and (1→3) β-d-Glucan Assays as Diagnostic Tools for Invasive Fungal Disease in Children, Adolescents, and Young Adults With Acute Myeloid Leukemia Receiving Fungal ProphylaxisBrian T Fisher, Ted Westling, Craig L K Boge, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Blood and marrow transplant clinical trials network state of the Science Symposium 2014Frederick R Appelbaum, Claudio Anasetti, Joseph H Antin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2011
Umbilical cord blood transplantation for children with thalassemia and sickle cell diseaseAnnalisa Ruggeri, Mary Eapen, Andromachi Scaravadou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2010
Generic immunosuppressants in hematopoietic cell transplantationCorey Cutler, Aaron Kesselheim, Steven Gabardi, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 15, 2013
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplantsJosephine Mauskopf, Costel Chirila, Jon Graham, et al.
Blood|October 31, 2008
Solid cancers after allogeneic hematopoietic cell transplantationJ Douglas Rizzo, Rochelle E Curtis, Gérard Socié, et al.
Transplantation and Cellular Therapy|October 23, 2022
Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of HematologyFareed Khawaja, Genovefa Papanicolaou, Sanjeet Dadwal, et al.
Blood Cancer Journal|November 28, 2017
Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemiaMaxim Norkin, Lakshmikanth Katragadda, Fei Zou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 20, 2011
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationNavneet S Majhail, J Douglas Rizzo, Stephanie J Lee, et al.
Pageof 27